Terugblik Nederland als Partnerland in 2014. Wirtschafsreport in gesprek met Marco Siebert, directeur Internationale betrekkingen Hannover Messe.
Exclusief interview met Marc Siemering over Hannover Messe 2016.
How can amputations be avoided?
Over six million people in Germany suffer from diabetes. Many of them also develop so-called diabetic foot as a consequence, and an estimated 50,000 amputations are carried out every year throughout the country. In an effort to reduce this high number of cases of invasive surgery, Dutch start-up Plasmacure from Eindhoven has developed a new patented treatment method. “With the help of a cold plasma pad, we are focusing on the early treatment and healing of chronic foot wounds in diabetes patients”, says the Founder and CEO Bas Zeper. Plasmacure will be showcasing the treatment method at the Dutch Pavilion at Hannover Messe and hopes to make new networking contacts.
The medical engineering company has its headquarters at the High Tech Campus Eindhoven in the HighTechXL Plaza. “I have worked here for a long time now and know the environment well. The campus is a great breeding ground for start-ups”, says Zeper. In a short space of time, Plasmacure managed to develop the cold plasma pad with a team of entrepreneurs and experts. Through mutual inspiration and shared knowledge, they are constantly working on the new product.
Reducing costs and guaranteeing quality of life
The cold plasma pad is an electronic plaster that helps wounds to heal better and faster. It is connected to a pulser, which provides the electric current for the plaster and induces the cold plasma. Zeper explains the advantages: “Our treatment effectively kills bacteria in the wound, stimulates tissue growth, improves local blood circulation and hence promotes the healing process.” The treatment, which is completely painless, lasts just one minute a day and needs to be repeated 20 to 30 times, depending on how inflamed the wound is. “This means that we can prevent amputations and in turn reduce treatment costs”, Zeper continues. Another crucial advantage is that patients get some quality of life back.
What makes the plaster concept unique is the pad’s flexibility, allowing it to adhere nicely to the wound. Each pad is used just once but the pulser is designed to be used repeatedly and lasts for a long time. The treatment can, for example, be administered by a podiatrist. “Patients usually visit the podiatrist regularly so they can also be treated directly by the experts there”, says Zeper. However, since it is so easy to operate, patients can also use the cold plasma pad themselves at home.
Safety-related pilot study
A clinical pilot study with a prototype is currently underway at the VU University Medical Center in Amsterdam. The project receives financial support from the Netherlands Diabetes Fund. The study is primarily focussed on ensuring that the cold plasma pad can be used safely, and is scheduled to run until summer 2017. The prototype should then be developed into a CE certified product by the end of 2018 or start of 2019. Plasmacure hopes to make lots of new contacts at Hannover Messe. “We are excited about people’s feedback on our ground-breaking product and hope to be able to expand our network in Germany in order to find potential partners who can help us to penetrate the German market”, says an excited Zeper.
A platform for start-ups
Around 20 innovative start-ups from the Netherlands will be exhibiting at the Start-up and Innovation Square in Hall 4 of Hannover Messe. They will be presenting their companies and showcasing their products to potential customers and investors under the auspices of high-tech experts from Holland Innovative.
Hall 4, Niederländische Gemeinschaftstand